UBE2C and central nervous system cancer: Targeting KIF11 and UBE2C using small molecule inhibitors Ispinesib and Monastrol (KIF11 inhibitors) and NSC697923 (UBE2C inhibitor) in the canine model of glioma can potentially be a promising therapeutic strategy for future evaluation in human GBM.